Last reviewed · How we verify
NCT07042217
Transcranial Direct Current Stimulation for Depression
NA trial testing transcranial direct current stimulation (tDCS) and mindfulness instruction in Unipolar Depression in 25 participants. Currently enrolling.
1 September 2026
Quick facts
| Lead sponsor | Soterix Medical |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 25 |
| Start date | 1 July 2025 |
| Primary completion | 1 September 2026 |
| Estimated completion | 1 September 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- transcranial direct current stimulation (tDCS) and mindfulness instruction
- Sham tDCS and Mindfulness
Conditions studied
- Unipolar Depression — all drugs for Unipolar Depression →
Sponsor
Soterix Medical — full company profile →
Who can join
22 and older, any sex, with Unipolar Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will test the efficacy of transcranial direct current stimulation (tDCS) combined with mindfulness, remotely-delivered using a telemedicine protocol in 25 adults with unipolar depression.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07042217
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Unipolar Depression
Currently open trials in the same condition.
- NCT07216404 — Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer · Phase 2 · recruiting
- NCT07266545 — RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE) · Phase 4 · recruiting
- NCT06860165 — Validation of EmoDTx as a Digital Endpoint for Mood Monitoring in Adult Patients Suffering From Unipolar Depression · recruiting
- NCT06472492 — Cognitive Enhancement in Unipolar Depression With Yoga · NA · recruiting
- NCT06934330 — Effect of Tao Calligraphy Meditation and Energized Water on Depression · NA · recruiting
Other Soterix Medical trials
Trials by the same sponsor.
- NCT07307768 — Ketamine Biomarker Validation · Phase 1 · not yet recruiting
- NCT07287839 — Parcel-guided rTMS for Major Depressive Disorder · Phase 2 · not yet recruiting
- NCT05598931 — Development of Neuro-Navigated Transcranial Magnetic Stimulation (TMS) Using MRI · completed
- NCT04956081 — Virtual Neuro-Navigation System for Personalized Community Based TMS · NA · completed
- NCT04781127 — Home-administered tDCS for Treatment of Depression · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07042217 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Soterix Medical
- Last refreshed: 10 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07042217.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing